Aclidinium use while Breastfeeding

Drugs containing Aclidinium: Tudorza Pressair

Medically reviewed on March 12, 2018

Aclidinium Levels and Effects while Breastfeeding

Summary of Use during Lactation

Although no published data exist on the use of aclidinium during breastfeeding, it produces low maternal serum levels because of rapid hydrolysis to inactive metabolites. The risk to the breastfed infant of maternal aclidinium inhalation is small.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Tiotropium, Umeclidinium

References

Aclidinium Identification

Substance Name

Aclidinium

CAS Registry Number

727649-81-2

Drug Class

Anti-Asthmatic Agents

Parasympatholytics

Cholinergic Antagonists

Bronchodilator Agents

Administrative Information

LactMed Record Number

1009

Disclaimer

Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer